Toxicity profile of silodosin (KMD-3213)

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Shin-ichi MutoNobuo Shibata

Abstract

The toxicity profile of silodosin, a selective alpha(1A)-adrenoceptor antagonist, was evaluated. The lethal doses were 800 mg/kg in rats and 1500 mg/kg in dogs. Repeated-dose studies revealed fatty degeneration of hepatocytes and an induction of drug-metabolizing enzymes at 15 mg/kg/day or more in male rats, mammary gland hyperplasia at 60 mg/kg/day or more in female rats, and degeneration of the seminiferous tubular epithelium at 25 mg/kg/day or more only in young dogs. Silodosin was negative in all mutagenicity studies, except for a weak positive in a chromosomal aberration assay conducted without metabolic activation. In carcinogenicity studies, mammary gland tumors and pituitary adenomas were increased in female mice given 150 mg/kg/day or more and 400 mg/kg/day respectively, while thyroid follicular cell carcinoma was increased in male rats given 150 mg/kg/day. Reproductive studies in rats revealed a decreased male fertility at 20 mg/kg/day or more and a prolonged estrous cycle at 60 mg/kg/day or more. Silodosin did not exhibit any teratogenic potential in either rats or rabbits, and had no effects on the postnatal development of rat offspring. In safety pharmacology studies, silodosin produced no severe effects on the cen...Continue Reading

References

Jan 1, 1991·Adverse Drug Reactions and Toxicological Reviews·R BassJ Manson
Apr 1, 1990·Contraception·W D Ratnasooriya, R M Wadsworth
Apr 1, 1989·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·E J de Castro e Silva, J Antunes-Rodrigues
May 1, 1989·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·R N HillC F Wilkinson
Jan 1, 1988·Reproductive Toxicology·R J Levine
Feb 27, 1984·The American Journal of Medicine·E Dall'AglioG M Reaven
Oct 12, 1999·Endocrine-related Cancer·B K Vonderhaar
May 29, 2002·Fundamental & Clinical Pharmacology·Gerd BodeUNKNOWN ICH Expert Working Group
Nov 6, 2003·Toxicology·Maritha Marcusson-Ståhl, Karin Cederbrant

❮ Previous
Next ❯

Related Concepts

Related Feeds

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.